Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Galli

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 12, 2014
Microparticle-loaded neonatal porcine Sertoli cells for cell-based therapeutic and drug delivery systemS Giovagnoli, F Mancuso, S Vannini, et al.
ESMO Open|December 4, 2022
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesotheliomaS Canova, G L Ceresoli, F Grosso, et al.
ESMO Open|February 3, 2026
Incidence and risk factors of brain metastases in radically resected melanoma patients: a large international cohort studyM Mandalà, P Rutkowski, R Patuzzo, et al.
ESMO Open|January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)M Reni, M Milella, F Bergamo, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2003
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessationC Cohen, O E Bergis, F Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioidsO Corli, I Floriani, A Roberto, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 10, 2024
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI surveyM Reni, E Giommoni, F Bergamo, et al.
The British Journal of Dermatology|April 14, 2020
The prognostic impact of the extent of ulceration in patients with clinical stage I-II melanoma: a multicentre study of the Italian Melanoma Intergroup (IMI)F Portelli, F Galli, L Cattaneo, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2016
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter studyS Rausei, L Ruspi, F Rosa, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 12, 2014
Microparticle-loaded neonatal porcine Sertoli cells for cell-based therapeutic and drug delivery systemS Giovagnoli, F Mancuso, S Vannini, et al.
ESMO Open|December 4, 2022
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesotheliomaS Canova, G L Ceresoli, F Grosso, et al.
ESMO Open|February 3, 2026
Incidence and risk factors of brain metastases in radically resected melanoma patients: a large international cohort studyM Mandalà, P Rutkowski, R Patuzzo, et al.
ESMO Open|January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)M Reni, M Milella, F Bergamo, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2003
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessationC Cohen, O E Bergis, F Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioidsO Corli, I Floriani, A Roberto, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 10, 2024
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI surveyM Reni, E Giommoni, F Bergamo, et al.
The British Journal of Dermatology|April 14, 2020
The prognostic impact of the extent of ulceration in patients with clinical stage I-II melanoma: a multicentre study of the Italian Melanoma Intergroup (IMI)F Portelli, F Galli, L Cattaneo, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2016
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter studyS Rausei, L Ruspi, F Rosa, et al.
Pageof 18